Impact of Various Exercise Modalities on Inflammatory Biomarkers in Heart Failure PatientsExercise training may lower inflammation in patients with heart failure

This network meta-analysis evaluated the impact of various exercise modalities on systemic inflammatory markers in patients with heart failure (HF), including those with reduced and preserved left-ventricular ejection fractions. The study analyzed the efficacy of aerobic training, resistance training (RT), combined training (CT), and Tai Chi/Yoga compared to control groups. The primary focus was on key pro-inflammatory cytokines, specifically interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-alpha), and C-reactive protein (CRP).

Regarding IL-6, the analysis demonstrated that any form of exercise training was more effective than standard care or control groups. Specifically, resistance training and Tai Chi/Yoga emerged as the most potent modalities for reducing IL-6 levels. These findings suggest that targeted physical interventions can effectively modulate specific cytokine pathways associated with chronic inflammation in the HF population.

For TNF-alpha, the data indicated that exercise training outperformed control groups. Within the exercise subgroups, combined training and aerobic training were identified as the optimal modalities for reducing these levels. This suggests that multi-modal approaches may provide a broader anti-inflammatory effect compared to single-modality exercises when targeting TNF-alpha specifically.

C-reactive protein (CRP) levels also showed significant reductions with exercise training compared to controls. Notably, combined training was identified as the most effective modality for lowering CRP levels. This indicates that a holistic approach combining different types of physical activity may be particularly beneficial for managing systemic inflammation markers.

While the results are promising, the study notes several limitations, including significant heterogeneity among the included studies and a relatively small number of primary studies. These factors necessitate a cautious interpretation of the data when applying these findings to clinical practice. However, the consistent trend across different markers suggests a positive role for physical activity.

Clinically, these findings suggest that exercise training may serve as a viable non-pharmacological intervention to manage chronic low-grade inflammation in heart failure patients. By selecting specific modalities—such as resistance training for IL-6 or combined training for CRP—clinicians may tailor physical therapy to address specific inflammatory profiles. Further large-scale, homogeneous trials are needed to confirm these specific modality advantages.